Binocular Vision Alternations and fMRI Activation After ICL Implantation for High Myopia

Binocular Vision Alternations and Functional Magnetic Resonance Imaging Activation After Implantable Collamer Lens Implantation for High Myopia

Implantable collamer lens (ICL) is one of the most effective operation for high myopia. Due to refractive correction changed, and prism effect of the spectacle removed, in the early stage after ICL implantation, binocular function might be dysfunction, leading to asthenopia, blurred vision, double vision and so on. This study will recruit the high myopia subjects that scheduled for ICL implantation, purpose to investigate the binocular vision alternations and brain activation that impacted by ICL implantation.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510060
        • Recruiting
        • Zhongshan Ophthalmic Center, Sun Yat-sen University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 31 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The high myopia subjects that scheduled for ICL implantation from Zhongshan Ophthalmic Center, Sun Yat-sen University

Description

Inclusion Criteria:

  • Age 18-35
  • Spherical equivalent over -6.00DS, astigmatism within -2.00DC, anisometropia within -2.00DS
  • BCVA ≥ 0.8
  • Plan to accept implantable collamer lens surgery
  • Near point of convergence within 10cm
  • Positive fusion vergence over 20pd

Exclusion Criteria:

  • Stabismus
  • Previous ocular surgery or trauma
  • History of vision therapy
  • Monovision and nystagmus
  • Mental disease or craniocerebral trauma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of phoria at different time points
Time Frame: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.
Phoria was measured by phoropter.
The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.
Changes of AC/A at different time points
Time Frame: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.
Gradient AC/A was measured by phoropter.
The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.
Changes of fusion vergence at different time points
Time Frame: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.
Fusion vergence was measured by phoropter.
The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.
Changes of accommodative response at different time points
Time Frame: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.
Accommodative response was measured using monocular estimated method.
The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.
Changes of relative accommodation at different time points
Time Frame: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.
Relative accommodation was measured by phoropter.
The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.
Changes of near point of convergence at different time points
Time Frame: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.
Near point of convergence was measured using push-up method.
The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.
Changes of accommodation amplitude at different time points
Time Frame: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.
Accommodative amplitude was measured using push-up method.
The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.
Changes of vergence facility at different time points
Time Frame: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.
Vergence facility was measured by +2.00D/-2.00D flipper.
The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.
Changes of accommodative facility at different time points
Time Frame: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.
Accommodative facility was measured by 3△BI/12△BO flipper.
The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of brain activation at different time points
Time Frame: The examination was performed before operation and 1 month, 6 monthes after ICL implantation.
Functional magnetic resonance imaging activation of the brain
The examination was performed before operation and 1 month, 6 monthes after ICL implantation.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2022

Primary Completion (Anticipated)

June 30, 2023

Study Completion (Anticipated)

June 30, 2023

Study Registration Dates

First Submitted

November 3, 2022

First Submitted That Met QC Criteria

November 30, 2022

First Posted (Actual)

December 1, 2022

Study Record Updates

Last Update Posted (Actual)

December 1, 2022

Last Update Submitted That Met QC Criteria

November 30, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Binocular Vision Disorder

Subscribe